Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrest
Blood level of SLC2A1 is a tentative blood biomarker that may aid in neurological outcome prediction after CA and also provide new insights into post-CA injury mechanisms.
Authors
- Claudia Schrag
- Jan Hovdenes (ORCID: https://orcid.org/0000-0002-7415-0525)
- Christian Rylander (ORCID: https://orcid.org/0000-0002-4534-7150)
- L Zhang
- Miron Sopić (ORCID: https://orcid.org/0000-0003-3283-9487)
- Michaël Kuiper (ORCID: https://orcid.org/0000-0001-6201-7332)
- Ondřej Šmíd (ORCID: https://orcid.org/0000-0001-9260-6509)
- Andrew I. Lumley (ORCID: https://orcid.org/0000-0001-5935-3327)
- Pascal Stammet (ORCID: https://orcid.org/0000-0002-0298-1012)
- Victoria Stopa (ORCID: https://orcid.org/0000-0002-2271-0551)
- Yvan Devaux
- Janneke Horn
- Christian Hassager
- J. Kjaergaard
- Tommaso Pellis
- Matt P. Wise
- Niklas Nielsen
Institutions
- Oslo University Hospital (NO)
- Uppsala University Hospital (SE)
- Centre Hospitalier de Luxembourg (LU)
- University of Luxembourg (LU)
- Charles University (CZ)
- Kantonsspital St. Gallen (CH)
- University Hospital of Wales (GB)
- Copenhagen University Hospital (DK)
- Medisch Centrum Leeuwarden (NL)
- Rigshospitalet (DK)
- University of Belgrade (RS)
- ASL Roma (IT)
- Luxembourg Institute of Health (LU)
- Amsterdam Neuroscience (NL)
- Helsingborgs lasarett (SE)
- General University Hospital in Prague (CZ)
Publication Details
- Journal
- Intensive Care Medicine Experimental
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1186/s40635-025-00851-8
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00